EP2894151
IMÍDASÓLÍN AFLEIÐUR, AÐFERÐIR TIL FRAMLEIÐSLU ÞEIRRA OG NOTKUN ÞEIRRA VIÐ LÆKNINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.8.2013EP published:
11.11.2020EP application number:
13835193.7
EP translation filed:
4.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
25.8.2033Expiry date:
25.8.2026Next due date:
31.8.2026
Title:
IMIDAZOLINE DERIVATIVES, PREPARATION METHODS THEREOF, AND THEIR APPLICATIONS IN MEDICINE
Timeline
Today
26.8.2013EP application
11.11.2020EP Publication
4.1.2021Translation submitted
15.2.2021Registration published
25.8.2026Expires
Owner
Name:
Shanghai Hengrui Pharmaceutical Co. Ltd.Address:
279 Wenjing Road, Minhang District Shanghai 200245, CN
Name:
Jiangsu Hengrui Medicine Co. Ltd.Address:
No. 7 Kunlunshan Road Economic and Technological Development Zone Lianyungang, Jiangsu 222047, CN
Inventor
Name:
LU, HejunAddress:
Shanghai 200245, CN
Name:
SUN, PiaoyangAddress:
Lianyungang Jiangsu 222047, CN
Name:
FEI, HongboAddress:
Shanghai 200245, CN
Name:
JIANG, HongjianAddress:
Shanghai 200245, CN
Name:
WANG, HaoweiAddress:
Shanghai 200245, CN
Name:
DONG, QingAddress:
Shanghai 200245, CN
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201210323870Date:
4.9.2012Country:
CN
Classification
Categories:
C07D 233/72, C07D 233/84, C07D 233/86, A61K 31/4164, A61K 31/4166, A61K 31/4178, A61P 5/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 10.8.2021
Expires: 25.8.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.7.2022
Expires: 25.8.2023
Payer: Acumass
Number: 11
Paid: 19.7.2023
Expires: 25.8.2024
Payer: Acumass
Number: 12
Paid: 17.7.2024
Expires: 25.8.2025
Payer: Acumass
Number: 13
Paid: 18.7.2025
Expires: 25.8.2026
Payer: Acumass